SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: N4ZQ who wrote (2039)10/3/1997 12:15:00 AM
From: JOHN W.   of 6136
 
Subject: Charting
Date: Thu, Oct 2, 1997 20:30 EDT
From: MillJacker
Message-id: <19971003003100.UAA16409@ladder02.news.aol.com>

Chartists will recognize that AGPH has made a classic divergent trend channel, starting in late May. It's quite authoritative: the basic trendline touches three bottoms, and the return line touches three tops.

The baseline was penetrated today, by two or three percent.

This is extremely significant. Something big is going to happen.

The flipped coin has landed on its edge. The golfball hangs on the lip of the cup.

This is as close to a 50-50 call as you'll ever see in charting.

I'm convinced it's going to cut both ways in favor of the longs. The shorts will call it a downside breakout, and wait for the price to get cheaper before they cover.

I call it a false penetration, an aberration resulting from light holiday volume. It may take four trading days, but we'll get a strong bounce.

We longs know Ag's fundamentals are brilliant, and next Tuesday after the close, 1Q results will begin to convince the market of this as no other evidence can.

Keep the faith.

Apologies to Edwards and Magee, and cheers,
John R
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext